The prion strain phenomenon: Molecular basis and unprecedented features

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1772, Issue 6, 2007, Pages 681-691

  Morales, Rodrigo ^a,b   Abid, Karim ^a   Soto, Claudio ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Creutzfeldt Jakob disease; Prion strains; Prions; Protein misfolding; Scrapie

Indexed keywords

NUCLEIC ACID; PRION PROTEIN; PROTEINASE;

ADAPTATION; BIOCHEMISTRY; ELECTROPHORETIC MOBILITY; EXPERIMENTAL ANIMAL; GLYCOSYLATION; HUMAN; INCUBATION TIME; INOCULATION; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN POLYMORPHISM; PUBLIC HEALTH; REVIEW; RISK; SEDIMENTATION;

ANIMALS; CREUTZFELDT-JAKOB SYNDROME; HUMANS; POLYMORPHISM, GENETIC; PRION DISEASES; PRIONS; SCRAPIE; TIME FACTORS;

ANIMALIA;

EID: 34249993165     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2006.12.006     Document Type: Review

References (133)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13363-13383
2. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu. Rev. Neurosci. 24 (2001) 519-550
3. Budka H., Aguzzi A., Brown P., Brucher J.M., Bugiani O., Gullotta F., Haltia M., Hauw J.J., Ironside J.W., and Jellinger K. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 5 (1995) 459-466
4. Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev., Neurosci. 4 (2003) 49-60
5. Cohen C.H., and Valleron A.J. When did bovine spongiform encephalopathy (BSE) start? Implications on the prediction of a new variant of Creutzfeldt-Jakob disease (nvCJD) epidemic. Int. J. Epidemiol. 28 (1999) 526-531
6. Ghani A.C., Ferguson N.M., Donnelly C.A., Hagenaars T.J., and Anderson R.M. Estimation of the number of people incubating variant CJD. Lancet 352 (1998) 1353-1354
7. Will R. Variant Creutzfeldt-Jakob disease. Folia Neuropathol. 42 (2004) 77-83 (Suppl A)
8. Griffith J.S. Self-replication and scrapie. Nature 215 (1967) 1043-1044
9. Cohen F.E., and Prusiner S.B. Pathologic conformations of prion proteins. Annu. Rev. Biochem. 67 (1998) 793-819
10. Prusiner S.B., Groth D.F., Bolton D.C., Kent S.B., and Hood L.E. Purification and structural studies of a major scrapie prion protein. Cell 38 (1984) 127-134
11. Chesebro B. BSE and prions: uncertainties about the agent. Science 279 (1998) 42-43
12. Soto C., and Castilla J. The controversial protein-only hypothesis of prion propagation. Nat. Med. 10 (2004) S63-S67
13. Bartz J.C., Bessen R.A., McKenzie D., Marsh R.F., and Aiken J.M. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy. J. Virol. 74 (2000) 5542-5547
14. Peretz D., Scott M.R., Groth D., Williamson R.A., Burton D.R., Cohen F.E., and Prusiner S.B. Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci. 10 (2001) 854-863
15. Pattison I.H., and Millson G.C. Scrapie produced experimentally in goats with special reference to the clinical syndrome. J. Comp. Pathol. 71 (1961) 101-109
16. Bessen R.A., and Marsh R.F. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J. Gen. Virol. 73 Pt 2 (1992) 329-334
17. Dickinson A.G. Scrapie in sheep and goats. Front Biol. 44 (1976) 209-241
18. Baylis M., and Goldmann W. The genetics of scrapie in sheep and goats. Curr. Mol. Med. 4 (2004) 385-396
19. Bruce M.E. Scrapie strain variation and mutation. Br. Med. Bull. 49 (1993) 822-838
20. Fraser H. Diversity in the neuropathology of scrapie-like diseases in animals. Br. Med. Bull. 49 (1993) 792-809
21. Westaway D., Goodman P.A., Mirenda C.A., McKinley M.P., Carlson G.A., and Prusiner S.B. Distinct prion proteins in short and long scrapie incubation period mice. Cell 51 (1987) 651-662
22. Bruce M.E., McBride P.A., and Farquhar C.F. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie. Neurosci. Lett. 102 (1989) 1-6
23. Bruce M.E., Boyle A., Cousens S., McConnell I., Foster J., Goldmann W., and Fraser H. Strain characterization of natural sheep scrapie and comparison with BSE. J. Gen. Virol. 83 (2002) 695-704
24. Lasmezas C.I., Deslys J.P., Demaimay R., Adjou K.T., Hauw J.J., and Dormont D. Strain specific and common pathogenic events in murine models of scrapie and bovine spongiform encephalopathy. J. Gen. Virol. 77 (1996) 1601-1609
25. Fraser H., and Dickinson A.G. Scrapie in mice. Agent-strain differences in the distribution and intensity of grey matter vacuolation. J. Comp. Pathol. 83 (1973) 29-40
26. Scott M.R., Will R., Ironside J., Nguyen H.O., Tremblay P., DeArmond S.J., and Prusiner S.B. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 15137-15142
27. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., and Bostock C.J. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389 (1997) 498-501
28. Bruce M.E., McConnell I., Fraser H., and Dickinson A.G. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J. Gen. Virol. 72 (1991) 595-603
29. Dickinson A.G., Meikle V.M., and Fraser H. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. J. Comp. Pathol. 78 (1968) 293-299
30. Dell'Omo G., Vannoni E., Vyssotski A.L., Di Bari M.A., Nonno R., Agrimi U., and Lipp H.P. Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences. Eur. J. Neurosci. 16 (2002) 735-742
31. Cunningham C., Deacon R.M., Chan K., Boche D., Rawlins J.N., and Perry V.H. Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol. Dis. 18 (2005) 258-269
32. Bessen R.A., and Marsh R.F. Biochemical and physical properties of the prion protein from two strains of the transmissible mink encephalopathy agent. J. Virol. 66 (1992) 2096-2101
33. Collinge J., Sidle K.C., Meads J., Ironside J., and Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383 (1996) 685-690
34. Parchi P., Castellani R., Capellari S., Ghetti B., Young K., Chen S.G., Farlow M., Dickson D.W., Sima A.A., Trojanowski J.Q., Petersen R.B., and Gambetti P. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39 (1996) 767-778
35. Khalili-Shirazi A., Summers L., Linehan J., Mallinson G., Anstee D., Hawke S., Jackson G.S., and Collinge J. PrP glycoforms are associated in a strain-specific ratio in native PrPSc. J. Gen. Virol. 86 (2005) 2635-2644
36. Safar J., Wille H., Itri V., Groth D., Serban H., Torchia M., Cohen F.E., and Prusiner S.B. Eight prion strains have PrP(Sc) molecules with different conformations. Nat. Med. 4 (1998) 1157-1165
37. Wadsworth J.D., Hill A.F., Joiner S., Jackson G.S., Clarke A.R., and Collinge J. Strain-specific prion-protein conformation determined by metal ions. Nat. Cell Biol. 1 (1999) 55-59
38. Caughey B., Raymond G.J., and Bessen R.A. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 273 (1998) 32230-32235
39. Aucouturier P., Kascsak R.J., Frangione B., and Wisniewski T. Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt-Jakob disease. Neurosci. Lett. 274 (1999) 33-36
40. Bellon A., Seyfert-Brandt W., Lang W., Baron H., Groner A., and Vey M. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. J. Gen. Virol. 84 (2003) 1921-1925
41. Jones E.M., and Surewicz W.K. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids. Cell 121 (2005) 63-72
42. Bruce M., Chree A., McConnell I., Foster J., Pearson G., and Fraser H. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos. Trans. R. Soc. Lond., B Biol. Sci. 343 (1994) 405-411
43. Fraser H., Bruce M.E., Chree A., McConnell I., and Wells G.A. Transmission of bovine spongiform encephalopathy and scrapie to mice. J. Gen. Virol. 73 (1992) 1891-1897
44. Muramoto T., Kitamoto T., Tateishi J., and Goto I. Successful transmission of Creutzfeldt-Jakob disease from human to mouse verified by prion protein accumulation in mouse brains. Brain Res. 599 (1992) 309-316
45. Hill A.F., and Collinge J. Prion strains and species barriers. Contrib. Microbiol. 11 (2004) 33-49
46. Peretz D., Williamson R.A., Legname G., Matsunaga Y., Vergara J., Burton D.R., DeArmond S.J., Prusiner S.B., and Scott M.R. A change in the conformation of prions accompanies the emergence of a new prion strain. Neuron 34 (2002) 921-932
47. Moore R.A., Vorberg I., and Priola S.A. Species barriers in prion diseases-brief review. Arch. Virol., Suppl. (2005) 187-202
48. Vanik D.L., Surewicz K.A., and Surewicz W.K. Molecular basis of barriers for interspecies transmissibility of mammalian prions. Mol. Cell 14 (2004) 139-145
49. Prusiner S.B., Scott M., Foster D., Pan K.M., Groth D., Mirenda C., Torchia M., Yang S.L., Serban D., and Carlson G.A. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication. Cell 63 (1990) 673-686
50. Chen S.G., and Gambetti P. A journey through the species barrier. Neuron 34 (2002) 854-856
51. Smith P.G., and Bradley R. Bovine spongiform encephalopathy (BSE) and its epidemiology. Br. Med. Bull. 66 (2003) 185-198
52. Collee J.G., and Bradley R. BSE: a decade on-Part I. Lancet 349 (1997) 636-641
53. Collee J.G., and Bradley R. BSE: a decade on-Part 2. Lancet 349 (1997) 715-721
54. A.F. Hill, M. Desbruslais, S. Joiner, K.C. Sidle, I. Gowland, J. Collinge, L.J. Doey, P. Lantos, The same prion strain causes vCJD and BSE. Nature 389 (1997) 448-50, 526.
55. Collinge J. Variant Creutzfeldt-Jakob disease. Lancet 354 (1999) 317-323
56. Gombojav A., Shimauchi I., Horiuchi M., Ishiguro N., Shinagawa M., Kitamoto T., Miyoshi I., Mohri S., and Takata M. Susceptibility of transgenic mice expressing chimeric sheep, bovine and human PrP genes to sheep scrapie. J. Vet. Med. Sci. 65 (2003) 341-347
57. Kirkwood J.K., and Cunningham A.A. Epidemiological observations on spongiform encephalopathies in captive wild animals in the British Isles. Vet. Rec. 135 (1994) 296-303
58. Pearson G.R., Wyatt J.M., Gruffydd-Jones T.J., Hope J., Chong A., Higgins R.J., Scott A.C., and Wells G.A. Feline spongiform encephalopathy: fibril and PrP studies. Vet. Rec. 131 (1992) 307-310
59. Taylor D.M., and Woodgate S.L. Bovine spongiform encephalopathy: the causal role of ruminant-derived protein in cattle diets. Rev. Sci. Tech. 16 (1997) 187-198
60. Bons N., Mestre-Frances N., Belli P., Cathala F., Gajdusek D.C., and Brown P. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4046-4051
61. Ryder S.J., Hawkins S.A., Dawson M., and Wells G.A. The neuropathology of experimental bovine spongiform encephalopathy in the pig. J. Comp. Pathol. 122 (2000) 131-143
62. Wells G.A., Hawkins S.A., Austin A.R., Ryder S.J., Done S.H., Green R.B., Dexter I., Dawson M., and Kimberlin R.H. Studies of the transmissibility of the agent of bovine spongiform encephalopathy to pigs. J. Gen. Virol. 84 (2003) 1021-1031
63. Castilla J., Gutierrez-Adan A., Brun A., Doyle D., Pintado B., Ramirez M.A., Salguero F.J., Parra B., Diaz S.S., Sanchez-Vizcaino J.M., Rogers M., and Torres J.M. Subclinical bovine spongiform encephalopathy infection in transgenic mice expressing porcine prion protein. J. Neurosci. 24 (2004) 5063-5069
64. Foster J.D., Hope J., and Fraser H. Transmission of bovine spongiform encephalopathy to sheep and goats. Vet. Rec. 133 (1993) 339-341
65. Stack M.J., Chaplin M.J., and Clark J. Differentiation of prion protein glycoforms from naturally occurring sheep scrapie, sheep-passaged scrapie strains (CH1641 and SSBP1), bovine spongiform encephalopathy (BSE) cases and Romney and Cheviot breed sheep experimentally inoculated with BSE using two monoclonal antibodies. Acta Neuropathol. (Berl) 104 (2002) 279-286
66. Wilesmith J.W., Wells G.A., Cranwell M.P., and Ryan J.B. Bovine spongiform encephalopathy: epidemiological studies. Vet. Rec. 123 (1988) 638-644
67. Wilesmith J.W., Ryan J.B., and Atkinson M.J. Bovine spongiform encephalopathy: epidemiological studies on the origin. Vet. Rec. 128 (1991) 199-203
68. Sigurdson C.J., and Miller M.W. Other animal prion diseases. Br. Med. Bull. 66 (2003) 199-212
69. Williams E.S. Chronic wasting disease. Vet. Pathol. 42 (2005) 530-549
70. Belay E.D., Gambetti P., Schonberger L.B., Parchi P., Lyon D.R., Capellari S., McQuiston J.H., Bradley K., Dowdle G., Crutcher J.M., and Nichols C.R. Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch. Neurol. 58 (2001) 1673-1678
71. Marsh R.F., Kincaid A.E., Bessen R.A., and Bartz J.C. Interspecies transmission of chronic wasting disease prions to squirrel monkeys (Saimiri sciureus). J. Virol. 79 (2005) 13794-13796
72. Hamir A.N., Cutlip R.C., Miller J.M., Williams E.S., Stack M.J., Miller M.W., O'Rourke K.I., and Chaplin M.J. Preliminary findings on the experimental transmission of chronic wasting disease agent of mule deer to cattle. J. Vet. Diagn. Invest. 13 (2001) 91-96
73. Hamir A.N., Kunkle R.A., Cutlip R.C., Miller J.M., O'Rourke K.I., Williams E.S., Miller M.W., Stack M.J., Chaplin M.J., and Richt J.A. Experimental transmission of chronic wasting disease agent from mule deer to cattle by the intracerebral route. J. Vet. Diagn. Invest. 17 (2005) 276-281
74. Hamir A.N., Miller J.M., Cutlip R.C., Stack M.J., Chaplin M.J., Jenny A.L., and Williams E.S. Experimental inoculation of scrapie and chronic wasting disease agents in raccoons (Procyon lotor). Vet. Rec. 153 (2003) 121-123
75. Kong Q., Huang S., Zou W., Vanegas D., Wang M., Wu D., Yuan J., Zheng M., Bai H., Deng H., Chen K., Jenny A.L., O'Rourke K., Belay E.D., Schonberger L.B., Petersen R.B., Sy M.S., Chen S.G., and Gambetti P. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J. Neurosci. 25 (2005) 7944-7949
76. Lasmezas C.I., Deslys J.P., Robain O., Jaegly A., Beringue V., Peyrin J.M., Fournier J.G., Hauw J.J., Rossier J., and Dormont D. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275 (1997) 402-405
77. Manuelidis E.E., Gorgacz E.J., and Manuelidis L. Transmission of Creutzfeldt-Jakob disease with scrapie-like syndromes to mice. Nature 271 (1978) 778-779
78. Tateishi J., Sato Y., Nagara H., and Boellaard J.W. Experimental transmission of human subacute spongiform encephalopathy to small rodents. IV. Positive transmission from a typical case of Gerstmann-Straussler-Scheinker's disease. Acta Neuropathol. (Berl) 64 (1984) 85-88
79. Kascsak R.J., Rubenstein R., Merz P.A., Carp R.I., Robakis N.K., Wisniewski H.M., and Diringer H. Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J. Virol. 59 (1986) 676-683
80. Rubenstein R., Merz P.A., Kascsak R.J., Scalici C.L., Papini M.C., Carp R.I., and Kimberlin R.H. Scrapie-infected spleens: analysis of infectivity, scrapie-associated fibrils, and protease-resistant proteins. J. Infect. Dis. 164 (1991) 29-35
81. Kascsak R.J., Rubenstein R., Merz P.A., Carp R.I., Wisniewski H.M., and Diringer H. Biochemical differences among scrapie-associated fibrils support the biological diversity of scrapie agents. J. Gen. Virol. 66 (1985) 1715-1722
82. Legname G., Nguyen H.O., Baskakov I.V., Cohen F.E., DeArmond S.J., and Prusiner S.B. Strain-specified characteristics of mouse synthetic prions. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2168-2173
83. Baron T., Crozet C., Biacabe A.G., Philippe S., Verchere J., Bencsik A., Madec J.Y., Calavas D., and Samarut J. Molecular analysis of the protease-resistant prion protein in scrapie and bovine spongiform encephalopathy transmitted to ovine transgenic and wild-type mice. J. Virol. 78 (2004) 6243-6251
84. Thackray A.M., Klein M.A., and Bujdoso R. Subclinical prion disease induced by oral inoculation. J. Virol. 77 (2003) 7991-7998
85. Tateishi J., Ohta M., Koga M., Sato Y., and Kuroiwa Y. Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents. Ann. Neurol. 5 (1979) 581-584
86. Collinge J., Owen F., Poulter M., Leach M., Crow T.J., Rossor M.N., Hardy J., Mullan M.J., Janota I., and Lantos P.L. Prion dementia without characteristic pathology. Lancet 336 (1990) 7-9
87. Medori R., Montagna P., Tritschler H.J., LeBlanc A., Cortelli P., Tinuper P., Lugaresi E., and Gambetti P. Fatal familial insomnia: a second kindred with mutation of prion protein gene at codon 178. Neurology 42 (1992) 669-670
88. Lloyd S.E., Thompson S.R., Beck J.A., Linehan J.M., Wadsworth J.D., Brandner S., Collinge J., and Fisher E.M. Identification and characterization of a novel mouse prion gene allele. Mamm. Genome 15 (2004) 383-389
89. Bessen R.A., and Marsh R.F. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J. Virol. 68 (1994) 7859-7868
90. Bessen R.A., Kocisko D.A., Raymond G.J., Nandan S., Lansbury P.T., and Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375 (1995) 698-700
91. Dickinson A.G., and Meikle V.M. Host-genotype and agent effects in scrapie incubation: change in allelic interaction with different strains of agent. Mol. Gen. Genet. 112 (1971) 73-79
92. Carp R.I., Moretz R.C., Natelli M., and Dickinson A.G. Genetic control of scrapie: incubation period and plaque formation in I mice. J. Gen. Virol. 68 (1987) 401-407
93. Carlson G.A., Kingsbury D.T., Goodman P.A., Coleman S., Marshall S.T., DeArmond S., Westaway D., and Prusiner S.B. Linkage of prion protein and scrapie incubation time genes. Cell 46 (1986) 503-511
94. Hunter N., Dann J.C., Bennett A.D., Somerville R.A., McConnell I., and Hope J. Are Sinc and the PrP gene congruent? Evidence from PrP gene analysis in Sinc congenic mice. J. Gen. Virol. 73 (1992) 2751-2755
95. Benestad S.L., Sarradin P., Thu B., Schonheit J., Tranulis M.A., and Bratberg B. Cases of scrapie with unusual features in Norway and designation of a new type, Nor98. Vet. Rec. 153 (2003) 202-208
96. Foster J.D., Parnham D., Chong A., Goldmann W., and Hunter N. Clinical signs, histopathology and genetics of experimental transmission of BSE and natural scrapie to sheep and goats. Vet. Rec. 148 (2001) 165-171
97. Tranulis M.A., Osland A., Bratberg B., and Ulvund M.J. Prion protein gene polymorphisms in sheep with natural scrapie and healthy controls in Norway. J. Gen. Virol. 80 (1999) 1073-1077
98. Collinge J., Palmer M.S., and Dryden A.J. Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337 (1991) 1441-1442
99. Palmer M.S., Dryden A.J., Hughes J.T., and Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352 (1991) 340-342
100. Lee H.S., Brown P., Cervenakova L., Garruto R.M., Alpers M.P., Gajdusek D.C., and Goldfarb L.G. Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J. Infect. Dis. 183 (2001) 192-196
101. Mead S., Stumpf M.P., Whitfield J., Beck J.A., Poulter M., Campbell T., Uphill J.B., Goldstein D., Alpers M., Fisher E.M., and Collinge J. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300 (2003) 640-643
102. Hauw J.J., Sazdovitch V., Laplanche J.L., Peoc'h K., Kopp N., Kemeny J., Privat N., Delasnerie-Laupretre N., Brandel J.P., Deslys J.P., Dormont D., and Alperovitch A. Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene. Neurology 54 (2000) 1641-1646
103. Parchi P., Giese A., Capellari S., Brown P., Schulz-Schaeffer W., Windl O., Zerr I., Budka H., Kopp N., Piccardo P., Poser S., Rojiani A., Streichemberger N., Julien J., Vital C., Ghetti B., Gambetti P., and Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46 (1999) 224-233
104. Goldfarb L.G., Petersen R.B., Tabaton M., Brown P., LeBlanc A.C., Montagna P., Cortelli P., Julien J., Vital C., and Pendelbury W.W. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258 (1992) 806-808
105. Hill A.F., Joiner S., Wadsworth J.D., Sidle K.C., Bell J.E., Budka H., Ironside J.W., and Collinge J. Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126 (2003) 1333-1346
106. Brandel J.P., Preece M., Brown P., Croes E., Laplanche J.L., Agid Y., Will R., and Alperovitch A. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362 (2003) 128-130
107. Bishop M.T., Hart P., Aitchison L., Baybutt H.N., Plinston C., Thomson V., Tuzi N.L., Head M.W., Ironside J.W., Will R.G., and Manson J.C. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 5 (2006) 393-398
108. Aguzzi A. Prion diseases of humans and farm animals: epidemiology, genetics, and pathogenesis. J. Neurochem. 97 (2006) 1726-1739
109. Collinge J., Beck J., Campbell T., Estibeiro K., and Will R.G. Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease. Lancet 348 (1996) 56
110. Glatzel M., Stoeck K., Seeger H., Luhrs T., and Aguzzi A. Human prion diseases: molecular and clinical aspects. Arch. Neurol. 62 (2005) 545-552
111. Gambetti P., Kong Q., Zou W., Parchi P., and Chen S.G. Sporadic and familial CJD: classification and characterisation. Br. Med. Bull. 66 (2003) 213-239
112. Parchi P., Zou W., Wang W., Brown P., Capellari S., Ghetti B., Kopp N., Schulz-Schaeffer W.J., Kretzschmar H.A., Head M.W., Ironside J.W., Gambetti P., and Chen S.G. Genetic influence on the structural variations of the abnormal prion protein. Proc. Natl. Acad. Sci. U. S. A 97 (2000) 10168-10172
113. Schoch G., Seeger H., Bogousslavsky J., Tolnay M., Janzer R.C., Aguzzi A., and Glatzel M. Analysis of prion strains by PrP(Sc) profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med. 3 (2005) e14
114. Puoti G., Rossi G., Giaccone G., Awan T., Lievens P.M., Defanti C.A., Tagliavini F., and Bugiani O. Polymorphism at codon 129 of PRNP affects the phenotypic expression of Creutzfeldt-Jakob disease linked to E200K mutation. Ann. Neurol. 48 (2000) 269-270
115. Bianca M., Bianca S., Vecchio I., Raffaele R., Ingegnosi C., and Nicoletti F. Gerstmann-Straussler-Scheinker disease with P102L-V129 mutation: a case with psychiatric manifestations at onset. Ann. Genet. 46 (2003) 467-469
116. Montagna P., Cortelli P., Avoni P., Tinuper P., Plazzi G., Gallassi R., Portaluppi F., Julien J., Vital C., Delisle M.B., Gambetti P., and Lugaresi E. Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol. 8 (1998) 515-520
117. Petersen R.B., Goldfarb L.G., Tabaton M., Brown P., Monari L., Cortelli P., Montagna P., Autilio-Gambetti L., Gajdusek D.C., and Lugaresi E. A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene). Mol. Neurobiol. 8 (1994) 99-103
118. Cortelli P., Gambetti P., Montagna P., and Lugaresi E. Fatal familial insomnia: clinical features and molecular genetics. J. Sleep Res. 8 Suppl. 1 (1999) 23-29
119. Hainfellner J.A., Parchi P., Kitamoto T., Jarius C., Gambetti P., and Budka H. A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann. Neurol. 45 (1999) 812-816
120. Liemann S., and Glockshuber R. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38 (1999) 3258-3267
121. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez G.F., Billeter M., Calzolai L., Wider G., and Wuthrich K. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 145-150
122. Wong B.S., Clive C., Haswell S.J., Williamson R.A., Burton D.R., Gambetti P., Sy M.S., Jones I.M., and Brown D.R. Copper has differential effect on prion protein with polymorphism of position 129. Biochem. Biophys. Res. Commun. 269 (2000) 726-731
123. Petchanikow C., Saborio G.P., Anderes L., Frossard M.J., Olmedo M.I., and Soto C. Biochemical and structural studies of the prion protein polymorphism. FEBS Lett. 509 (2001) 451-456
124. Mulcahy E.R., and Bessen R.A. Strain-specific kinetics of prion protein formation in vitro and in vivo. J. Biol. Chem. 279 (2004) 1643-1649
125. Puoti G., Giaccone G., Rossi G., Canciani B., Bugiani O., and Tagliavini F. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 53 (1999) 2173-2176
126. Pocchiari M., Puopolo M., Croes E.A., Budka H., Gelpi E., Collins S., Lewis V., Sutcliffe T., Guilivi A., Delasnerie-Laupretre N., Brandel J.P., Alperovitch A., Zerr I., Poser S., Kretzschmar H.A., Ladogana A., Rietvald I., Mitrova E., Martinez-Martin P., Pedro-Cuesta J., Glatzel M., Aguzzi A., Cooper S., Mackenzie J., van Duijn C.M., and Will R.G. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 127 (2004) 2348-2359
127. Brown P., Rodgers-Johnson P., Cathala F., Gibbs Jr. C.J., and Gajdusek D.C. Creutzfeldt-Jakob disease of long duration: clinicopathological characteristics, transmissibility, and differential diagnosis. Ann. Neurol. 16 (1984) 295-304
128. Dickinson A.G., Fraser H., and Outram G.W. Scrapie incubation time can exceed natural lifespan. Nature 256 (1975) 732-733
129. Kimberlin R.H., and Walker C.A. Competition between strains of scrapie depends on the blocking agent being infectious. Intervirology 23 (1985) 74-81
130. Bartz J.C., Aiken J.M., and Bessen R.A. Delay in onset of prion disease for the HY strain of transmissible mink encephalopathy as a result of prior peripheral inoculation with the replication-deficient DY strain. J. Gen. Virol. 85 (2004) 265-273
131. Weissmann C., and Aguzzi A. Approaches to therapy of prion diseases. Annu. Rev. Med. 56 (2005) 321-344
132. Soto C., Kascsak R.J., Saborio G.P., Aucouturier P., Wisniewski T., Prelli F., Kascsak R., Mendez E., Harris D.A., Ironside J., Tagliavini F., Carp R.I., and Frangione B. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides. Lancet 355 (2000) 192-197
133. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Dwek R.A., Burton D.R., and Prusiner S.B. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412 (2001) 739-743